Unlock your Market Access Potential
Having a strong cost- effectiveness model or innovative market access strategy can pay dividends in the competitive therapeutic area. Our experts in Health Economics and Outcome Research have extensive experience in different health economic methodologies and help you finding the optimal and fastest way to make your innovative products accessible to the patients that need them.
What's your need?
We are experienced and able to support you with any of the below requirements.
[Your need is not listed? Contact us to see if we can help or recommend one of our partners].
- Discrete choise experiment
- Patients reported ourcomes , ePRO
- Cost effectiveness analysis
- Budget impact analysis
- Value- added cost effectiveness analysis
Your Benefits When Choosing Datametrix
With offices in Switzerland (Neuchâtel), Sweden (Molndal at the AstraZeneca BioHub) and North Africa, we have always embraced virtual team working solutions and techniques. We connect rapidly and readily – through virtual media or in person.
Reliability & Expertise
Ensuring the delivery of your projects on time, to the expected standards and within budget, we have a team of highly qualified data analysts and biostatisticians with extensive experience and deep expertise.
Ability to Adapt
to Your Scope
Your needs come first. Our core skills are around data analytics, biostatistics, HEOR, data management and programming. Our large network or partners enables us to broaden our range of services, including clinical operations project management, field monitoring and site management.
Cost-Effectiveness to Compete
What's our "Flexible FSP" Model?
This working model, that we like to call “Super Flexible”, offers strong benefits to your team:
- Focused resources
- Multiregional presence and localized customer support
- Enhanced productivity
- Accelerating recruitment timelines
Ask us any question directly below.
We will get back to you within maximum 24 hours.
Prefer jumping on a call?
Read inspiring stories.
To receive notifications about our latest developments
and similar stories and challenge to yours, subscribe to our Datametrix